2 patients treated for TAA,
only 11% required reintervention at 60 months of
follow-up.206 Indications for reintervention were type I
endoleaks in about 7% and infection and type III endoleaks in 1% each. No secondary intervention was performed for aneurysm expansion or endograft collapse.206
In contrast, 63 consecutive patients treated in Essen,
Germany, with TEVAR for PA